Bernd Brust, President, Molecular Medicine at Life Technologies Corp (LIFE), sold 6,250 shares at $56.00 ($350K) on 2010-12-29, disclosed to the SEC on 2011-01-03.
Scheduled sale ($350k) by President, Molecular Medicine under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LIFE | SELL | 2011-01-04 | $670K | — | Filing → |
| LIFE | SELL | 2010-12-06 | $1.7M | — | Filing → |
| LIFE | SELL | 2010-03-02 | $611K | — | Filing → |